Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial
Download the PDF here.
This post appeared first on investingnews.com
Cardiol Therapeutics President and CEO, David Elsley PRISM MarketView announces the release of an informative…
Forum Energy Metals Corp. (TSXV: FMC) (OTCQB: FDCFF) (‘Forum’ or the ‘Company’) announced today that…
(TheNewswire) December 19th, 2024 TheNewswire – Vancouver, B.C. Opawica Explorations Inc. (TSXV: OPW) (FSE: A2PEAD)…
AgTech Company highlights recent 100% purchase of Hemp Carbon Standard platform to advance industrial hemp…
Investor and author Gianni Kovacevic shared his thoughts on copper market dynamics, saying that while…